242 related articles for article (PubMed ID: 25563312)
1. Clinical efficacy of oral ganciclovir for prophylaxis and treatment of recurrent herpes simplex keratitis.
Wang X; Wang L; Wu N; Ma X; Xu J
Chin Med J (Engl); 2015 Jan; 128(1):46-50. PubMed ID: 25563312
[TBL] [Abstract][Full Text] [Related]
2. [Clinical assessment of oral ganciclovir capsules on the treatment of herpes simplex keratitis].
Wang X; Xu JJ; LE QH; Wang Y; Wang WT
Zhonghua Yan Ke Za Zhi; 2010 Nov; 46(11):994-9. PubMed ID: 21211295
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and safety of 0.15% ganciclovir in situ ophthalmic gel for herpes simplex keratitis - a multicenter, randomized, investigator-masked, parallel group study in Chinese patients.
Lin T; Gong L; Sun XH; Zhao NQ; Chen W; Yuan HP; Shao Y; Gao MH; Tang H
Drug Des Devel Ther; 2013; 7():361-8. PubMed ID: 23761964
[TBL] [Abstract][Full Text] [Related]
4. 6-Thioguanine Inhibits Herpes Simplex Virus 1 Infection of Eyes.
Chen D; Liu Y; Zhang F; You Q; Ma W; Wu J; Wu Z
Microbiol Spectr; 2021 Dec; 9(3):e0064621. PubMed ID: 34730435
[TBL] [Abstract][Full Text] [Related]
5. Acyclovir for the treatment and prevention of recurrent infectious herpes simplex keratitis.
Wu X; Chen X
Chin Med J (Engl); 2002 Oct; 115(10):1569-72. PubMed ID: 12490113
[TBL] [Abstract][Full Text] [Related]
6. Recurrent herpetic keratitis despite antiviral prophylaxis: A virological and pharmacological study.
Rousseau A; Boutolleau D; Titier K; Bourcier T; Chiquet C; Weber M; Colin J; Gueudry J; M'Garrech M; Bodaghi B; Burrel S; Agut H; Deback C; ; Labetoulle M
Antiviral Res; 2017 Oct; 146():205-212. PubMed ID: 28939476
[TBL] [Abstract][Full Text] [Related]
7. [Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis].
Shimomura Y
Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):247-64; discussion 265. PubMed ID: 18411713
[TBL] [Abstract][Full Text] [Related]
8. Dipeptide monoester ganciclovir prodrugs for treating HSV-1-induced corneal epithelial and stromal keratitis: in vitro and in vivo evaluations.
Majumdar S; Nashed YE; Patel K; Jain R; Itahashi M; Neumann DM; Hill JM; Mitra AK
J Ocul Pharmacol Ther; 2005 Dec; 21(6):463-74. PubMed ID: 16386088
[TBL] [Abstract][Full Text] [Related]
9. The effect of topical application of 0.15% ganciclovir gel on cytomegalovirus corneal endotheliitis.
Koizumi N; Miyazaki D; Inoue T; Ohtani F; Kandori-Inoue M; Inatomi T; Sotozono C; Nakagawa H; Horikiri T; Ueta M; Nakamura T; Inoue Y; Ohashi Y; Kinoshita S
Br J Ophthalmol; 2017 Feb; 101(2):114-119. PubMed ID: 27142389
[TBL] [Abstract][Full Text] [Related]
10. Tetrandrine potently inhibits herpes simplex virus type-1-induced keratitis in BALB/c mice.
Hu S; Dutt J; Zhao T; Foster CS
Ocul Immunol Inflamm; 1997 Sep; 5(3):173-80. PubMed ID: 9326762
[TBL] [Abstract][Full Text] [Related]
11. Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis.
Barron BA; Gee L; Hauck WW; Kurinij N; Dawson CR; Jones DB; Wilhelmus KR; Kaufman HE; Sugar J; Hyndiuk RA
Ophthalmology; 1994 Dec; 101(12):1871-82. PubMed ID: 7997323
[TBL] [Abstract][Full Text] [Related]
12. Acute Herpetic Keratitis: What is the Role for Ganciclovir Ophthalmic Gel?
Sahin A; Hamrah P
Ophthalmol Eye Dis; 2012; 4():23-34. PubMed ID: 23650455
[TBL] [Abstract][Full Text] [Related]
13. Ganciclovir ophthalmic gel (Virgan; 0.15%) in the treatment of herpes simplex keratitis.
Colin J; Hoh HB; Easty DL; Herbort CP; Resnikoff S; Rigal D; Romdane K
Cornea; 1997 Jul; 16(4):393-9. PubMed ID: 9220235
[TBL] [Abstract][Full Text] [Related]
14. Ganciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitis.
Kaufman HE; Haw WH
Curr Eye Res; 2012 Jul; 37(7):654-60. PubMed ID: 22607463
[TBL] [Abstract][Full Text] [Related]
15. Long-term comparison of full-bed deep lamellar keratoplasty with penetrating keratoplasty in treating corneal leucoma caused by herpes simplex keratitis.
Wu SQ; Zhou P; Zhang B; Qiu WY; Yao YF
Am J Ophthalmol; 2012 Feb; 153(2):291-299.e2. PubMed ID: 21996306
[TBL] [Abstract][Full Text] [Related]
16. Prevention of herpes simplex virus induced stromal keratitis by a glycoprotein B-specific monoclonal antibody.
Krawczyk A; Dirks M; Kasper M; Buch A; Dittmer U; Giebel B; Wildschütz L; Busch M; Goergens A; Schneweis KE; Eis-Hübinger AM; Sodeik B; Heiligenhaus A; Roggendorf M; Bauer D
PLoS One; 2015; 10(1):e0116800. PubMed ID: 25587898
[TBL] [Abstract][Full Text] [Related]
17. Clinical Features of Herpes Simplex Keratitis in a Korean Tertiary Referral Center: Efficacy of Oral Antiviral and Ascorbic Acid on Recurrence.
Kim GN; Yoo WS; Park MH; Chung JK; Han YS; Chung IY; Seo SW; Yoo JM; Kim SJ
Korean J Ophthalmol; 2018 Oct; 32(5):353-360. PubMed ID: 30311457
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of low-dose and long-term oral acyclovir therapy after penetrating keratoplasty for herpes simplex heratitis.
Akova YA; Onat M; Duman S
Ocul Immunol Inflamm; 1999 Mar; 7(1):51-60. PubMed ID: 10410875
[TBL] [Abstract][Full Text] [Related]
19. [Penetrating keratoplasty in active herpes simplex stromal keratitis].
Dong X; Shi W; Xie L
Zhonghua Yan Ke Za Zhi; 2001 Mar; 37(2):118-20. PubMed ID: 11864405
[TBL] [Abstract][Full Text] [Related]
20. Herpetic Eye Disease Study: A Controlled Trial of Topical Corticosteroids for Herpes Simplex Stromal Keratitis.
Wilhelmus KR; Gee L; Hauck WW; Kurinij N; Dawson CR; Jones DB; Barron BA; Kaufman HE; Sugar J; Hyndiuk RA; Laibson PR; Stulting RD; Asbell PA;
Ophthalmology; 2020 Apr; 127(4S):S5-S18. PubMed ID: 32200827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
